查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654297

全球败血症药物市场：市场规模、份额、趋势分析（按药物类别、给药途径、分销管道和地区）、细分市场预测（2025-2030 年）

Sepsis Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Glycopeptide, Aminoglycosides), By Route Of Administration (Parenteral, Oral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 153 Pages | 商品交期: 2-10个工作天内

价格

败血症药物市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球败血症药物市场预计到2030年将达到56.4亿美元，2025年至2030年期间的复合年增长率为6.18%。

由于败血症盛行率不断上升以及对有效治疗方案的需求不断增长，败血症药物产业正在经历显着增长。败血症是一种由感染疾病引起的危及生命的疾病，也是全世界的主要死亡原因，尤其是对于老年人和免疫力等弱势群体。人们对败血症的认识不断提高，以及医疗保健基础设施的进步，推动了对新型有效治疗方法的需求，从而促进了市场成长。

推动市场扩大的主要因素是用于治疗的抗生素种类繁多。Aminoglycosides抗生素，例如庆大霉素，由于其对革兰氏阴性细菌具有频谱活性，仍然是败血症治疗的主要药物。此外，头孢菌素也被广泛使用，因为它们能有效治疗多种感染疾病，特别是由革兰氏阳性菌引起的感染疾病。万古霉素等糖肽在败血症的治疗中也发挥重要作用，尤其是对抗药性感染疾病。卡巴培南类和β-内酰胺类抗生素等其他药物类别的存在进一步扩展了治疗前景。

败血症药物有多种形式，包括口服、肠外（注射）和其他製剂，使其用途广泛且可供各种医疗环境中的患者使用。口服药物对于门诊治疗很方便，而对于需要即时介入的严重病例，肠外製剂是不可或缺的。其他剂型的日益普及也支持了个人化医疗。

在通路方面，医院药房仍然是败血症药物的一级资讯来源，确保重症监护室备有必要的药物。零售药局透过提供可轻鬆取得的药品来扩大其作用，而网路药局则透过提供易于取得的败血症药物而获得市场认可，进一步推动了市场成长。随着全球医疗保健机会和治疗意识的不断提高，败血症药物产业将在未来几年继续扩张。

败血症药物市场报告重点

  • 依药物类别划分，头孢菌素类在 2024 年占据最大的市场占有率。这项优点是由于头孢菌素对多种细菌感染具有广谱功效，包括革兰氏阳性病原体和革兰氏阴性病原体。
  • 根据给药途径，肠外製剂在 2024 年占据市场主导地位。肠外製剂，包括静脉注射和肌肉注射，具有快速输送和高生物利用度的特点，因此对于脓毒症的即时治疗至关重要，尤其是对于重症患者。
  • 根据分销管道，医院药房将在 2024 年继续占据主导地位。医院药局对于确保及时和适当提供败血症药物至关重要，特别是在加护病房(ICU) 和急诊室，因为快速获得救生护理至关重要。
  • 由于先进的医疗基础设施、疾病盛行率上升以及有利的法规环境等因素，北美将在 2024 年主导败血症药物市场。

目录

第一章 分析方法及范围

第 2 章执行摘要

3. 败血症药物市场：驱动因素、趋势与范围

  • 母市场展望
  • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 败血症药物市场：分析工具
    • 波特五力分析
    • PESTEL 分析

第 4 章 败血症药物市场：展望、估计与预测（按类型）

  • 败血症药物市场：按类型分類的仪表板
  • 败血症药物市场：按类型进行趋势分析（2024 年和 2030 年）
  • 头孢菌素
  • Aminoglycosides
  • 糖肽
  • 其他药物类别

第 5 章 败血症药物市场：展望、估计与依给药途径预测

  • 败血症药物市场：按给药途径分類的仪表板
  • 败血症药物市场：依给药途径进行的变化分析（2024 年和 2030 年）
  • 肠外
  • 口服
  • 其他的

第 6 章败血症药物市场：展望、估计与按分销管道预测

  • 败血症药物市场：按分销管道分類的仪表板
  • 败血症药物市场：按分销管道分類的趋势分析（2024 年和 2030 年）
  • 医院药房
  • 零售药局
  • 网路药局

第 7 章败血症药物市场：展望、估计与区域预测

  • 败血症药物市场占有率（按地区划分） (2024 年和 2030 年)
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 挪威
    • 瑞典
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
    • 南非

第八章 竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司热图分析
  • 公司简介
    • Pfizer, Inc.
    • GSK plc.
    • AstraZeneca
    • Eli Lilly and Company
    • Astellas Pharma Inc.
    • Asahi Kasei Corporation
    • InflaRx GmbH
    • La Jolla Pharmaceutical Co.
    • T2 Biosystems Inc.
    • Aridis Pharmaceuticals Inc.
Product Code: GVR-4-68040-506-0

Sepsis Therapeutics Market Growth & Trends:

The global sepsis therapeutics market size is anticipated to reach USD 5.64 billion by 2030, growing at a CAGR of 6.18% from 2025 to 2030, according to a new report by Grand View Research, Inc. The sepsis therapeutics industry is experiencing significant growth due to the increasing prevalence of sepsis and the rising demand for effective treatment options. Sepsis, a life-threatening condition triggered by an infection, is a leading cause of mortality globally, particularly among vulnerable populations such as the elderly and those with compromised immune systems. The growing awareness about sepsis, alongside advancements in healthcare infrastructure, is driving the demand for novel and effective therapies, propelling market growth.

A key factor contributing to the expansion of the market is the wide range of antibiotics used in the treatment. Aminoglycosides, such as gentamicin, continue to be a mainstay in sepsis management due to their broad-spectrum activity against Gram-negative bacteria. Additionally, cephalosporins are widely prescribed because of their effectiveness in treating various infections, especially those caused by Gram-positive bacteria. Glycopeptides, such as vancomycin, are also critical in sepsis therapy, particularly for resistant infections. The presence of other drug classes like carbapenems and beta-lactams further enhances the treatment landscape.

The availability of sepsis therapeutics in various forms, including oral, parenteral (injectable), and other formulations, ensures better accessibility and versatility for patients across different healthcare settings. Oral medications are convenient for outpatient treatment, while parenteral formulations are vital for severe cases requiring immediate intervention. The growing availability of other drug forms also supports personalized care.

In terms of distribution channels, hospital pharmacies continue to be the primary source of sepsis therapeutics, ensuring that critical care units are stocked with necessary treatments. Retail pharmacies are expanding their role in providing accessible medications, while online pharmacies are gaining traction by offering easy access to sepsis drugs, further boosting market growth. As healthcare access and treatment awareness increase globally, the sepsis therapeutics industry is poised for continued expansion in the coming years.

Sepsis Therapeutics Market Report Highlights:

  • The drug class segment of cephalosporins held the largest market share in 2024. This dominance can be attributed to the broad-spectrum efficacy of cephalosporins against a wide range of bacterial infections, including both Gram-positive and Gram-negative pathogens.
  • In the route of administration segment, parenteral formulations dominated the market in 2024. Parenteral drugs, including intravenous and intramuscular injections, offer rapid delivery and higher bioavailability, making them essential for the immediate treatment of sepsis, especially in critical care settings.
  • Based on distribution channel, hospital pharmacies remained the dominant segment in 2024. Hospital pharmacies are critical in ensuring timely and adequate provision of sepsis therapeutics, particularly in intensive care units (ICUs) and emergency departments where quick access to lifesaving treatments is essential.
  • North America dominated the market for sepsis therapeutics in 2024, owing to factors such as advanced healthcare infrastructure, rising disease prevalence, and favorable regulatory environment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Sepsis Therapeutics Market Variables, Trends, & Scope

  • 3.1. Parent Market Outlook
  • 3.2. Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Increasing prevalence of sepsis cases
      • 3.3.1.2. Advancements in modern therapeutics
      • 3.3.1.3. Rising investment in sepsis research and drug development
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. High cost of advanced therapies
      • 3.3.2.2. Lack of awareness and early diagnosis in some regions
  • 3.4. Sepsis Therapeutics Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Sepsis Therapeutics Market: Type Estimates & Trend Analysis

  • 4.1. Sepsis Therapeutics Market: Type Segment Dashboard
  • 4.2. Sepsis Therapeutics Market: By Type Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Cephalosporin
    • 4.3.1. Cephalosporin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Aminoglycosides
    • 4.4.1. Aminoglycosides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Glycopeptide
    • 4.5.1. Glycopeptide Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Other Drug Class
    • 4.6.1. Other Drug Class Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Sepsis Therapeutics Market: Route of Administration Estimates & Trend Analysis

  • 5.1. Sepsis Therapeutics Market: Route of Administration Segment Dashboard
  • 5.2. Sepsis Therapeutics Market: By Route of Administration Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Parenteral
    • 5.3.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Sepsis Therapeutics Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Sepsis Therapeutics Market: Distribution Channel Segment Dashboard
  • 6.2. Sepsis Therapeutics Market: Distribution Channel Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Retail Pharmacies
    • 6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Online Pharmacies
    • 6.5.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Sepsis Therapeutics Market: Regional Estimates & Trend Analysis

  • 7.1. Sepsis Therapeutics Market Share, By Region, 2024 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Sepsis Therapeutics Market Estimates and Forecasts, 2018- 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Norway
      • 7.3.8.1. Norway Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Sweden Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Sepsis Therapeutics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. Kuwait
      • 7.6.4.1. Kuwait Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. South Africa Sepsis Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Pfizer, Inc.
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. GSK plc.
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. AstraZeneca
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Eli Lilly and Company
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Astellas Pharma Inc.
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Asahi Kasei Corporation
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. InflaRx GmbH
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. La Jolla Pharmaceutical Co.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. T2 Biosystems Inc.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Aridis Pharmaceuticals Inc.
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 4 Global Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 5 Global Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 6 North America Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 8 North America Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 9 North America Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 10 U.S. Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 11 U.S. Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 U.S. Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 Canada Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 14 Canada Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 15 Canada Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Mexico Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 17 Mexico Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 18 Mexico Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 19 Europe Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 21 Europe Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 22 Europe Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 23 Germany Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 24 Germany Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 25 Germany Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 UK Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 27 UK Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 28 UK Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 France Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 30 France Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 31 France Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 Italy Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 33 Italy Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 34 Italy Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 Spain Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 36 Spain Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 37 Spain Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 Denmark Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 39 Denmark Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 40 Denmark Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 Sweden Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 42 Sweden Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 43 Sweden Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Norway Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Norway Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 46 Norway Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51 China Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 52 China Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 53 China Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 Japan Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 55 Japan Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 56 Japan Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 57 India Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 58 India Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 59 India Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 60 South Korea Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 61 South Korea Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 62 South Korea Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 63 Australia Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 64 Australia Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 65 Australia Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66 Thailand Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 67 Thailand Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 68 Thailand Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69 Latin America Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 71 Latin America Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 72 Latin America Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 Brazil Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 74 Brazil Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 75 Brazil Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 76 Argentina Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 77 Argentina Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 78 Argentina Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Sepsis Therapeutics Market, by Country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 South Africa Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 84 South Africa Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 85 South Africa Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 89 UAE Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 90 UAE Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 91 UAE Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Sepsis Therapeutics Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Sepsis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Sepsis Therapeutics Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Sepsis therapeutics market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Market challenge relevance analysis (current & future impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Sepsis therapeutics market: Drug class movement analysis
  • Fig. 16 Sepsis therapeutics market: Drug class Outlook and key takeaways
  • Fig. 17 Cephalosporin sepsis therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 18 Aminoglycosides sepsis therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 19 Glycopeptide sepsis therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 20 Glycopeptide sepsis therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 21 Sepsis therapeutics market: Treatment movement analysis
  • Fig. 22 Sepsis therapeutics market: Treatment outlook and key takeaways
  • Fig. 23 Parenteral market estimates and forecasts, 2018 - 2030
  • Fig. 24 Oral market estimates and forecasts, 2018 - 2030
  • Fig. 25 Others market estimates and forecasts, 2018 - 2030
  • Fig. 26 Sepsis therapeutics market: Distribution channel movement analysis
  • Fig. 27 Sepsis therapeutics market: Distribution channel outlook and key takeaways
  • Fig. 28 Hospital pharmacies market estimates and forecasts, 2018 - 2030
  • Fig. 29 Retail pharmacies market estimates and forecasts, 2018 - 2030
  • Fig. 30 Online pharmacies market estimates and forecasts, 2018 - 2030
  • Fig. 31 Regional Marketplace: Key Takeaways
  • Fig. 32 Regional Outlook, 2024 & 2030
  • Fig. 33 Global sepsis therapeutics market, Region Movement Analysis
  • Fig. 34 North America sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 40 UK sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 41 France sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 42 Italy sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 43 Spain sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 46 Norway sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 48 Japan sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 49 China sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 50 India sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 51 Australia sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 60 UAE sepsis therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait sepsis therapeutics market, 2018 - 2030 (USD Million)